MedTrace Logo

Health Effects of CLA Versus Industrial Trans Fatty Acids

NCT00529828 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2008-01-16

No results posted yet for this study

Summary

The knowledge of the health effects of CLA on the human body is limited. However, CLA supplements are sold over the counter in several countries and various techniques are used to increase the content of CLA in food.

The CLARINeT study will be performed to investigate the effect of CLA on blood lipoproteins, inflammatory markers, blood pressure and insulin status in human volunteers relative to industrial trans fatty acids and to oleic acid.

Conditions

  • Healthy

Interventions

PROCEDURE

Consumption of CLA enriched food

Sponsors & Collaborators

  • VU University of Amsterdam

    collaborator OTHER

  • Wageningen University

    lead OTHER

Principal Investigators

  • Ingeborg Brouwer, Dr. · VU University of Amsterdam

  • Martijn Katan, Prof. Dr. · VU University of Amsterdam

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00529828 on ClinicalTrials.gov